This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Healy, D. Articles by Savage, M. Search for Related Content PubMed PubMed Citation Articles by Healy, D. Articles by Savage, M. Social Bookmarking                         What's this?

Suicide in the course of the treatment of depression

C. Langmaak

M. Savage

NorthWales Department of Psychological Medicine, Bangor LL57 2PW, UK

Five different mechanisms have been proposed whereby antidepressant treatment might lead to suicide: first by simply ameliorating depressions more rapidly; second by an action intrinsic to the specific antidepressant effects; third by toxicity in overdose; fourth by side-effects of specific antidepressants; and finally by virtue of treatment inefficacy. Evidence from randomized control trials (RCT), controlled case studies and epidemiological studies on this question is reviewed and it is concluded that antidepressants can be implicated in some cases of suicide during treatment. Modifications of clinical trial methods and pharmacogenetic studies would yield a richer data set to explore this issue further.

Key Words: akathisia • antidepressants • behavioural toxicity • case reports • suicide

Journal of Psychopharmacology, Vol. 13, No. 1, 94-99 (1999)
DOI: 10.1177/026988119901300110


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				A. James Pharmacotherapy and child psychiatry: is there a way forward?: INVITED COMMENTARY ON... CHILD PSYCHIATRY AND ITS RELATIONSHIP WITH THE PHARMACEUTICAL INDUSTRY Adv. Psychiatr. Treat., January 1, 2008; 14(1): 10 - 16. [Abstract] [Full Text] [PDF]

				D. Gunnell, J. Saperia, and D. Ashby Do selective serotonin reuptake inhibitors cause suicide?: Authors' reply to Curtin and Schulz, and Healy BMJ, May 14, 2005; 330(7500): 1148 - 1149. [Full Text]

				J. Caballero and M. C. Nahata Selective serotonin-reuptake inhibitors and suicidal ideation and behavior in children Am. J. Health Syst. Pharm., April 15, 2005; 62(8): 864 - 867. [Full Text] [PDF]

				D. Gunnell, J. Saperia, and D. Ashby Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review BMJ, February 19, 2005; 330(7488): 385. [Abstract] [Full Text] [PDF]

				P. R Finley Antidepressants, Suicide, and the FDA: A Loose Association Ann. Pharmacother., October 1, 2004; 38(10): 1739 - 1742. [Full Text] [PDF]

				D. J. Nutt Death and Dependence: Current Controversies over the Selective Serotonin Reuptake Inhibitors J Psychopharmacol, December 1, 2003; 17(4): 355 - 364. [Abstract] [PDF]

				A. Khan, S. Khan, R. Kolts, and W. A. Brown Suicide Rates in Clinical Trials of SSRIs, Other Antidepressants, and Placebo: Analysis of FDA Reports Am J Psychiatry, April 1, 2003; 160(4): 790 - 792. [Abstract] [Full Text] [PDF]

				D. Healy A dance to the music of the century: Changing fashions in 20th-century psychiatry The Psychiatrist, January 1, 2000; 24(1): 1 - 3. [Full Text]

				D. Wilkinson Loss of anxiety and increased aggression in a 15-year-old boy taking fluoxetine J Psychopharmacol, July 1, 1999; 13(4): 420 - 420. [PDF]